MERCK & CO., INC. (MRK)
Clinical trial NCT00001373: enrollment: not set → 5000 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT07489495: enrollment: not set → 758 participants.
NEUREN PHARMACEUTICALS LTD. (NURPF)
Clinical trial NCT07281079: enrollment: not set → 160 participants.
INTELLIGENT BIO SOLUTIONS INC. (INBS)
Clinical trial NCT07611123 updates: 1. start date: 2025-11-02 → 2026-04-28 2. completion date: 2026-05-01 → 2026-05-10 3. primary completion date: 2025-11-02 → 2026-05-10 4. enrollment: not set → 94 participants
ASTRAZENECA PLC (AZN)
Clinical trial NCT07307781: enrollment: not set → 500 participants.
AGIOS PHARMACEUTICALS, INC. (AGIO)
Clinical trial NCT07241234 updates: 1. start date: 2026-04-21 → 2026-04-17 2. enrollment: not set → 20 participants
ABBVIE INC. (ABBV)
Clinical trial NCT05995353: enrollment: not set → 110 participants.
ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT04184895: enrollment: not set → 28 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT06824467: enrollment: not set → 770 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT06890884: enrollment: not set → 594 participants.